Details about Toshiaki Iizuka

Access statistics for papers by Toshiaki Iizuka.

Last updated 2025-01-06. Update your information in the RePEc Author Service.

Short-id: pii8

Working Papers

2024

1. Robots and Labor in Nursing Homes
   NBER Working Papers, National Bureau of Economic Research, Inc

2023

2. Long-term Care in Japan
   NBER Working Papers, National Bureau of Economic Research, Inc

2021

3. Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare
   Discussion Papers, Department of Economics, Simon Fraser University View citations (2)
   Also in NBER Working Papers, National Bureau of Economic Research, Inc (2020)
   See also Journal Article Asymmetric Demand Response When Prices Increase and Decrease: The Case of Child Health Care, The Review of Economics and Statistics, MIT Press (2023) View citations (2) (2023)
4. Is Zero a Special Price? Evidence from Child Healthcare
   Discussion Papers, Department of Economics, Simon Fraser University View citations (1)
   See also Journal Article Is Zero a Special Price? Evidence from Child Health Care, American Economic Journal: Applied Economics, American Economic Association (2022) View citations (7) (2022)
5. Robots and Labor in the Service Sector: Evidence from Nursing Homes
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)

2019

6. Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
   See also Journal Article Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems, The European Journal of Health Economics, Springer (2020) View citations (1) (2020)
7. Free for Children? Patient Cost-sharing and Healthcare Utilization
   CEI Working Paper Series, Center for Economic Institutions, Institute of Economic Research, Hitotsubashi University
   Also in NBER Working Papers, National Bureau of Economic Research, Inc (2018) View citations (8)

2017

8. False Alarm? Estimating the Marginal Value of Health Signals
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
   See also Journal Article False alarm? Estimating the marginal value of health signals, Journal of Public Economics, Elsevier (2021) View citations (13) (2021)

2016

9. Promoting Innovation in Small Markets: Evidence from the market for rare and intractable diseases
   Discussion papers, Research Institute of Economy, Trade and Industry (RIETI)
   See also Journal Article Promoting innovation in small markets: Evidence from the market for rare and intractable diseases, Journal of Health Economics, Elsevier (2017) View citations (1) (2017)

2005

10. Drug Advertising and Health Habit
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)

Journal Articles

2023

1. Asymmetric Demand Response When Prices Increase and Decrease: The Case of Child Health Care
   The Review of Economics and Statistics, 2023, 105, (5), 1325-1333 View citations (2)
   See also Working Paper Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare, Discussion Papers (2021) View citations (2) (2021)
2. Effect of age-based left-digit bias on stroke diagnosis: Regression discontinuity design
   Social Science & Medicine, 2023, 334, (C)

2022

3. Comment on “Sustainable Health Financing for COVID‐19 Preparedness and Response in Asia and the Pacific”
   Asian Economic Policy Review, 2022, 17, (1), 159-160 View citations (1)
4. Is Zero a Special Price? Evidence from Child Health Care
   American Economic Journal: Applied Economics, 2022, 14, (4), 381-410 View citations (7)
   See also Working Paper Is Zero a Special Price? Evidence from Child Healthcare, Discussion Papers (2021) View citations (1) (2021)

2021

5. False alarm? Estimating the marginal value of health signals
   Journal of Public Economics, 2021, 195, (C) View citations (13)
   See also Working Paper False Alarm? Estimating the Marginal Value of Health Signals, NBER Working Papers (2017) View citations (6) (2017)

2020

6. Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems
   The European Journal of Health Economics, 2020, 21, (5), 689-702 View citations (1)
   See also Working Paper Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems, NBER Working Papers (2019) View citations (2) (2019)

2017

7. Promoting innovation in small markets: Evidence from the market for rare and intractable diseases
   Journal of Health Economics, 2017, 54, (C), 56-65 View citations (1)
   See also Working Paper Promoting Innovation in Small Markets: Evidence from the market for rare and intractable diseases, Discussion papers (2016) (2016)

2016

8. Cartel sustainability in retail markets: Evidence from a health service sector
   International Journal of Industrial Organization, 2016, 49, (C), 36-58 View citations (2)
9. Patient cost sharing and medical expenditures for the Elderly
   Journal of Health Economics, 2016, 45, (C), 115-130 View citations (30)
10. The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program
    Health Economics, 2016, 25, (11), 1433-1447 View citations (10)

2015

11. Comment on “How does the Price Regulation Policy Impact on Patient–Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?”
    Asian Economic Policy Review, 2015, 10, (2), 326-327 View citations (1)

2014

12. DURABLE GOODS PRICE CYCLES: THEORY AND EVIDENCE FROM THE TEXTBOOK MARKET
    Economic Inquiry, 2014, 52, (2), 518-538 View citations (4)

2013

13. Does Higher Malpractice Pressure Deter Medical Errors?
    Journal of Law and Economics, 2013, 56, (1), 161 - 188 View citations (27)

2012

14. Physician Agency and Adoption of Generic Pharmaceuticals
    American Economic Review, 2012, 102, (6), 2826-58 View citations (77)

2011

15. The generic drug market in Japan: will it finally take off?
    Health Economics, Policy and Law, 2011, 6, (3), 369-389 View citations (3)

2009

16. GENERIC ENTRY IN A REGULATED PHARMACEUTICAL MARKET*
    The Japanese Economic Review, 2009, 60, (1), 63-81 View citations (10)

2007

17. An Empirical Analysis of Planned Obsolescence
    Journal of Economics & Management Strategy, 2007, 16, (1), 191-226 View citations (15)
18. DIRECT TO CONSUMER ADVERTISING AND PRESCRIPTION CHOICE
    Journal of Industrial Economics, 2007, 55, (4), 771-771 View citations (34)
19. Experts' agency problems: evidence from the prescription drug market in Japan
    RAND Journal of Economics, 2007, 38, (3), 844-862 View citations (119)

2005

20. The Effect of Prescription Drug Advertising on Doctor Visits
    Journal of Economics & Management Strategy, 2005, 14, (3), 701-727 View citations (49)

2004

21. What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs?
    Journal of Industrial Economics, 2004, 52, (3), 349-379 View citations (30)